CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that its Chief Operating Officer, Julianne ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

For sufferers of sickle cell disease, agonising pain and fear are a cruel part of everyday life. But a major breakthrough has brought much-needed hope for the UK’s 17,500 patients, with a £1 ...

The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its first cystic fibrosis (CF) drug -- Kalydeco -- back in 2012 and has since ...

Vertex Pharmaceuticals generated more than $11 billion in product revenue last year thanks to its dominance in cystic fibrosis treatment. Progress in that specialty area and two key drug approvals ...

Kylie Jenner has come under fire for allegedly treating Timothee Chalamet like a 'possession', with their relationship likened to that of a mother and son rather than a romantic couple, following ...

We conducted a retrospective analysis of individuals who had been tested for CYP genetics to determine the prevalence of DDIs, DGIs and DDGIs in the sample. Approval for the study was obtained ...

With a market cap of $124.9 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology company. The Boston, Massachusetts-based company engages in developing and ...

Despite advancements in medical care, pregnant women with sickle cell disease (SCD) are at a higher risk of complications and require close monitoring, a nationwide French study has found. SCD is ...

Expert Rev Endocrinol Metab. 2008;3(6):771-775. Kateri McCarthy, Developmental Endocrinology Branch, National Institute of Child Health and Human Development, National Institutes of Health ...